Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective analysis of aortic bypasses and valve surgeries with conventional versus half-dose systemic heparinization
2007-005070-31Phase 4Active
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Oct 2007
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of heparin in Cardiac valve disease (VHD) and Aortic heart disease (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Peri- and postoperative bleeding. Started Oct 2007; status: active.
02
Drugs
heparin
03
Conditions
Cardiac valve disease (VHD)Aortic heart disease
Beyond the preview
Go deeper on 2007-005070-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005070-31.